Revvity (NYSE:RVTY) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Revvity (NYSE:RVTY) from a hold rating to a buy rating in a report issued on Saturday.

RVTY has been the subject of a number of other research reports. The Goldman Sachs Group started coverage on Revvity in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $105.00 target price for the company. Barclays increased their price objective on Revvity from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Tuesday, February 3rd. Robert W. Baird set a $129.00 target price on shares of Revvity in a report on Tuesday, February 3rd. Weiss Ratings raised shares of Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday. Finally, TD Cowen reissued a “hold” rating on shares of Revvity in a research report on Tuesday, February 3rd. Five investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $113.67.

Revvity Trading Down 2.7%

NYSE:RVTY opened at $95.65 on Friday. The company has a 50-day moving average price of $103.26 and a 200-day moving average price of $96.55. The stock has a market cap of $10.69 billion, a price-to-earnings ratio of 45.99, a P/E/G ratio of 2.09 and a beta of 1.10. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36. Revvity has a 12 month low of $81.36 and a 12 month high of $120.39.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The company had revenue of $772.06 million during the quarter, compared to the consensus estimate of $759.81 million. During the same period in the prior year, the firm earned $1.42 earnings per share. Revvity’s revenue was up 5.9% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Equities analysts predict that Revvity will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Friday, April 17th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Friday, April 17th. Revvity’s dividend payout ratio (DPR) is currently 13.46%.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. CYBER HORNET ETFs LLC purchased a new stake in shares of Revvity in the second quarter worth $32,000. Cromwell Holdings LLC grew its position in shares of Revvity by 141.4% during the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after purchasing an additional 198 shares in the last quarter. MUFG Securities EMEA plc bought a new position in Revvity in the 2nd quarter worth approximately $34,000. Headlands Technologies LLC purchased a new stake in Revvity during the 2nd quarter valued at approximately $49,000. Finally, Los Angeles Capital Management LLC purchased a new position in Revvity during the fourth quarter valued at $51,000. 86.65% of the stock is currently owned by institutional investors.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.